Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
for
Pulmonary Disease, Chronic Obstructive
Location: Doral FL, Lake Charles LA
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT07780669
Phase3, Recruiting
Viral Mucosal Reprogramming
for
Asthma, Allergic Rhinitis, Cat Allergy, Healthy
Location: Galveston TX
Sponsor: The University of Texas Medical Branch, Galveston
Sex: All
Age: 18 - 60
Code: NCT05331170
Phase2, Recruiting
Trial to Determine Effective Aspirin Dose in COPD
for
Pulmonary Disease, Chronic Obstructive
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 40 - 70+
Code: NCT05265299
Phase3, Recruiting
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
for
Pulmonary Disease, Chronic Obstructive
Location: Bangor ME, West Chester PA, Kingston, Miami FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT07177339
Phase3, Recruiting
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
for
Pulmonary Disease, Chronic Obstructive
Location: Miami FL, Loxahatchee Groves FL, Rock Hill SC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT06959095
Phase3, Recruiting
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
for
Pulmonary Disease, Chronic Obstructive
Location: Bangor ME, Mount Kisco NY, New Windsor NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT06961214
Phase3, Recruiting
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
for
Cancer-Associated Thrombosis (CAT)
Location: North Miami Beach FL, Hialeah FL, El Paso TX
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07410117
Phase3, Recruiting
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Boston MA, Providence RI, Norwalk CT, New York NY,
Sponsor: Fore Biotherapeutics
Sex: All
Age: 8+
Code: NCT05503797
Phase2, Recruiting
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy